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Abstract
Background: Two lineages of Zika virus (ZIKV) have been classified according to the phylogenetic analysis: African
and Asian lineages. It is unclear whether differences exist between the two strains in host cell permissiveness, this
information is important for understanding viral pathogenesis and designing anti-viral strategies.
Methods: In the present study, we comparatively studied the permissive spectrum of human cells for both the African
(MR766) and Asian strains (PRVABC59) using an RNA in situ hybridization (RISH) to visualize RNA replication, an
immunofluorescence technology, and a western blot assay to determine viral protein production, and a real-time
RT-PCR to examine viral RNA multiplication level. The experiments were undertaken in the condition of cell culture.
Results: We identified several human cell lines, including fibroblast, epithelial cells, brain cells, stem cells, and blood
cells that are susceptible for the infection of both Asian and African strains. We did not find any differences between
the MR766 and the PRVABC59 in the permissiveness, infection rate, and replication modes. Inconsistent to a previous
report (Hamel et al. JVI 89:8880–8896, 2015), using RISH or real-time RT-PCR, we found that human foreskin fibroblast
cells were not permissive for ZIKV infection. Instead, human lung fibroblast cells (MRC-5) were fully permissive for ZIKV
infection. Surprisingly, a direct interaction of ZIKV RNA with envelop (E) protein (a structure protein) was demonstrated
by an RNA chromatin immunoprecipitation (ChIP) assay. Three binding sites were identified in the ZIKV RNA genome
for the interaction with the E protein.
Conclusion: Our results imply that the E protein may be important for viral RNA replication, and provide not only the
information of ZIKV permissiveness that guides the usage of human cells for the ZIKV studies, but also the insight into
the viral RNA-E protein interaction that may be targeted for intervention by designing small molecule drugs.
Keywords: Zika virus (ZIKV), RNA in situ hybridization (RISH), Permissiveness, RNA Chromatin Immunoprecipitation
(ChIP), RNA replication
Background
Zika virus (ZIKV) has recently drawn worldwide attention
due to the recent outbreaks that are temporally and
spatially consistent with the increased occurrence of
congenital microcephaly and Guillain–Barré syndrome
(GBS) in the Americas. Recently, an increasing number of
strains of ZIKV have been isolated from more than 60
countries since its first isolation in Uganda in 1947 [1, 2].
Phylogenetic studies classified ZIKV into Asian and
African lineages [3, 4]. For unknown reasons, the Asian
lineage ZIKV has been linked to recent epidemics and
most likely the congenital microcephaly and GBS while
African strains cause milder symptoms. The recent cases
of microcephaly and GBS linked to ZIKV are mostly, if
not all, caused by the strains of Asian lineage [5]. How-
ever, more experimental evidence is needed to support the
hypothesis that ZIKVs from the two lineages are different
in viral replication, pathogenesis, transmission, and cell
permissiveness.
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The first ZIKV was isolated from a monkey, and it is
known that ZIKV can be transmitted by being bitten by
the infected Aedes species of mosquito [6, 7] or sexually
between humans [8, 9]. The known primary hosts of
ZIKV include human, monkey, and mosquito. During
the evolution of ZIKV, the virus may have developed
new molecular relationships with factors of the host
cells. Only a few human cells are known to be permis-
sive for ZIKV replication including an epithelial cell line
(A549), neural stem cells [10], and a skin fibroblast cell
line [11]. It remains unknown whether other cell lines
are permissive for the infection of ZIKV.
Little is known regarding the interaction of ZIKV pro-
teins and RNA with the host or viral factors although
the interactions may determine the fate and/or efficiency
of infection, pathogenicity, transmission, and epidemic
potential of the ZIKV. It therefore remains important to
determine the spatial relationship between the viral pro-
teins and RNA replication. Of equal importance is their
temporal relationship, whether the viral RNA replication
occurs before protein production.
Belonging to family Flaviviridae, ZIKV contains a posi-
tive single stranded RNA (ssRNA) genome with a size
around 11 k nucleotides (nt). After infecting permissive
cells, the ZIKV genome is translated into a precursor
protein (a polyprotein) at a size of about 3424 amino
acid (Aa). The precursor protein is then co- and post-
translationally processed by viral and cellular proteases
into 3 structural and 7 non-structural (NS) proteins.
Viral replication has been demonstrated in mitochondria
and endoplasmic reticulum (ER) [12]. Viral RNA replica-
tion has not been characterized for ZIKV. In the present
study, we determined the viral permissiveness in differ-
ent human cell lines using anti-viral antibody, real-time
RT-PCR, and RNA in situ hybridization (RISH), then we
examined the interaction between the viral RNA and E
protein by an RNA ChIP (Chromatin Immunoprecipita-
tion) assay.
Methods
Cell lines, Tissue Culture, and Viruses
To examine the spectrum of the permissiveness of ZIKV
in cells, we infected different cell lines listed in Table 1
where the sources and types of the cells are indicated.
The cells were maintained in the Minimum Essential
Medium Eagle (MEM, Sigma M4655) supplemented
with 10% fetal calf serum (FCS) and penicillin (100 IU/
ml)-streptomycin (100 μg/ml) and amphotericin B (2.5
μg/ml). The peripheral blood mononuclear cell (PBMC),
CEM T cells, and THP-1 monocytes were cultured in
RPMI 1640 supplemented with 10% fetal calf serum
(FCS) and penicillin (100 IU/ml)-streptomycin (100
μg/ml) [13]. ZIKV strains MR766 [14] and PRVABC59
[4] were obtained from ATCC.
Antibodies
Anti-Giantin (ab24586) for visualizing Golgi body,
anti-Cox IV (ab16056) for showing mitochondria, and
anti-Calreticulin (ab196156) for examining endoplasmic
reticulum (ER) were purchased from Abcam (Cambridge,
MA). The anti-ZIKV envelope antibody was generated
from the hybridoma cell line, D1-4G2–4-15 (ATCC® HB-
112™) and anti-ZIKV serum was produced from ZIKV-
infected mice in our laboratory.
Western blot assay
Viral and cellular proteins in the whole cell lysate
(WCL) samples were separated by 7.5% sodium dodecyl
Table 1 Cell Permissiveness of Zika Virus (ZIKV)
Host cell infected ZIKV (MR766) ZIKV (PRVABC59)
Protein RNA Protein RNA
Human fibroblast cells
HFF (ATCC® SCRC-1041™) − − − −
MRC-5 (ATCC® CCL-171™) ++++ ++++ ++++ ++++
BJ (ATCC® CRL-2522™) +/− − +/− −
Human Epithelial cells
ARPE-19 (ATCC® CRL-2302™) + + + +
A549 (ATCC® CCL-185™) ++ ++ ++ ++
HT1080 (ATCC® CCL-121™) +/− +/− +/− +/−
Hep-2 (ATCC® CCL-23™) − − − −
HEK 293T(ATCC® CRL-1573™) + + + +/−
Human Endothelial cells
SLK (AIDSRP, cat# 9402) − − − −
Human blood cells
CEM/CD4 T cell (AIDSRP, cat# 117) +/− +/− +/− +/−
THP-1 (AIDSRP, cat# 9949) − − − −
PBMC (ATCC® PCS-800-011™) ++ ++ ++ ++
Other Human cells
U-251MG (SIGMA 09063001) ++++ ++++ ++++ ++++
Neural Stem cell +++ +++ +++ +++
SK-N-SH (ATCC® HTB-11™) ++++ ++++ ++++ ++++
Simian cells
Vero (ATCC® CCL-81™) ++++ ++++ ++++ ++++
COS7 (ATCC® CRL-1651™) ++++ ++++ ++++ ++++
Mouse cells
MEF − − − −
NIH3T3 (ATCC® CRL-1658™) − − − −
The cells were infected with ZIKV at an MOI of 1 for 48 h, and fixed to perform
immunostaining using anti-ZIKV antibody and RISH (RNA in situ hybridization)
using the probe against ZIKV genome. Total cells (DAPI) and positive cells
(ZIKV protein and/or RNA replication) were counted to calculate the positive
rate (Positive rate = positive cell counted / total cells counted). HFF human
foreskin fibroblast, MEF mouse embryo fibroblast. -: less than 3%; +/−: 3–5%;
+: 5–10%; ++: 10–30%; +++: 30–70%; More than 70% positive rate defines ++
++. AIDSRP AIDS Reagent Program
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sulfate-polyacrylamide gel electrophoresis (10 to 20 μg
loaded in each lane using Novex NuPAGE SDS-PAGE
Gel System purchased from ThermoFisher Scientific.),
transferred to nitrocellulose membranes (Amersham
Inc., Piscataway, NJ), and blocked with 5% nonfat milk
for 60 min at room temperature. Membranes were incu-
bated overnight at 4 °C with primary antibody followed
by incubation with a horseradish peroxidase-coupled
secondary antibody (Amersham Inc.) and detection with
enhanced chemiluminescence (Pierce, Rockford, Ill.), ac-
cording to standard methods. Membranes were stripped
with stripping buffer (100 mM β-mercaptoethanol, 2%
SDS, 62.5 mM Tris-HCl, pH 6.8), washed with 0.1%
PBS-Tween 20, and used to detect additional proteins.
RNA isolation and real-time RT-PCR
Following instructions of the manufacturers, total RNA
was isolated using Aurum™ Total RNA Mini Kit (Bio-
Rad, Cat# 732–6820). To quantitatively examine the
RNA level of ZIKV from the infected cells, real-time RT-
PCR was undertaken using the SsoAdvanced™ Universal
SYBR Green Supermix kit (Bio-Rad, Hercules, CA). The
primers for ZIKV were: forward- 5′-AAATACACATAC-
CAAAACAAAGTGGT-3′ and reverse- 5′-
TCCACTCCCTCTCTGGTCTTG-3′; and the primers
for beta-actin (as control) were: forward- 5′
-GGTTCCGATGCCCTGAGGCTC-3′ and reverse- 5′-
ACTTGCGGTGCACGATGGAGG -3′. 0.5–2 μg of
total RNA and 250 nM of sense and antisense primers
(amplifying the RNA fragment in NS5 location) were
used in a final 10 μl volume containing 100 ng of cDNA
for all samples except for PBMC, which had 25 ng of
cDNA. PCR reactions consisted of 40 cycles with the fol-
lowing optimal conditions: 95 °C for 30 s followed by a
two-step PCR reaction of 95 °C for 15 s and 60 °C for
30 s. All samples were run in technical triplicates, and
the data were collected and recorded by the CFX Man-
ager software (Bio-Rad). The data was analyzed using
2ΔΔCq = (Cq,Target-Cq,Actin)Time X - (Cq,Target-Cq,Actin)Time 0
to obtain the fold change in expression via the 2ΔΔCq
method Time 0 was used as the calibrator of the relative
quantification of product generated in the exponential
phase of the amplification curve for real-time RT-PCR.
A melting temperature curve analysis was obtained by
measuring (after the amplification cycles) the fluores-
cence during a period of warming from 65 to 95 °C.
RNA Chromatin immunoprecipitation (ChIP) assay
The ChIP assay was carried out according to the manu-
facturer’s manual using an EZ ChIP kit purchased from
Millipore (Temecula, CA). Briefly, Vero cells were in-
fected with ZIKV MR766 for 24 h. The cells were cross-
linked with 1% paraformaldehyde and then sonicated to
shear the DNA/RNA. The RNA-protein complexes were
pulled down by anti-ZIKV serum that was generated and
purified in our laboratory and normal mouse IgG (used
as negative control). The cross-linked RNA-protein
complexes were then washed with multiple buffers
(provided by the EZ ChIP kit) and reversed by SDS at
95 °C; the DNA was removed by DNase I digestion, the
proteins were removed by proteinase K, and the RNA
was purified through the provided column. Real-time
RT-PCR was performed to examine the amount of RNA
in each sample using the primers shown in Table 2.
Immunocytochemistry and fluorescence in situ
hybridization
Cells grown on coverslips, and immunostaining was
performed after fixation with 1% paraformaldehyde
(10 min at room temperature) and permeabilization in
0.2% Triton (20 min on ice) by sequential incubation
with primary and Texas red (TR) -labeled secondary
antibodies (Vector Laboratories, Burlingame, Calif.) for
30 min each (all solutions in PBS). For simultaneous
detection of ZIKV RNA, cells were first immunostained
for cellular or viral proteins and then treated for 1 h at
Table 2 Primers for the ZIKV RNA ChIP assays
Sequence Start nt End nt
Forward AGTTGTTGATCTGTGTGAGTCAG 1 23
Reverse GCATATTGACAATCCGGAATCCT 133 156
Forward GATTCCGGATTGTCAATATGCTAAA 135 160
Reverse GTGATGGCTTGATTGCTGTAAA 272 294
Forward AGCCATCACTGGGCCTT 285 302
Reverse TAGTCAGCAGGAGGCCAAT 443 462
Forward TCCTGCTGACTACAGCCAT 450 469
Reverse TGCCCGAGGTCCATGAT 584 601
Forward CAAGTGCCACGTACAGATCAT 568 589
Reverse TAGATCGCCGTGCCTCA 730 747
Forward GCACGGCGATCTAGAAGAG 734 753
Reverse AATGGCAACGGCCACTA 882 899
Forward TAGTGGCCGTTGCCATTG 882 900
Reverse AAGACAACATCAACCCAGGTC 1030 1051
Forward TGGGTACCAACTGGGAGAA 10,031 10,050
Reverse TCCTAGATAGGGAATGTCTGTCC 10,170 10,193
Forward AAATGGACAGACATTCCCTATCT 10,166 10,189
Reverse TAGCGGACTTGGGTGGATA 10,323 10,342
Forward TATCCACCCAAGTCCGCTAC 10,323 10,343
Reverse CGTTCTCGGCCTGACTATGA 10,475 10,495
Forward CTCATAGTCAGGCCGAGAAC 10,474 10,494
Reverse CACAGCTAGTCTCCAGTTCAG 10,623 10,644
Forward GAACTGGAGACTAGCTGTGAAT 10,625 10,646
Reverse GCTGTTCGGCGATCTGT 10,760 10,776
Based on the nt sequence of MR766
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37 °C with RNase-free DNase I (Roche, Indianapolis,
Ind.; 200 U/ml in PBS containing 25 mM MgCl2). After
refixation in 4% paraformaldehyde (10 min at room
temperature), samples were equilibrated in 2× SSC (1×
SSC is 0.15 M NaCl plus 0.015 M sodium citrate), dehy-
drated in ethanol (70, 80, and 100% ethanol for 3 min
each at −20 °C), air dried, and incubated overnight at
37 °C with the hybridization mixture. To detect RNA,
only the probe DNA was denatured at 94 °C for 5 min.
After hybridization, samples were washed at 37 °C with
55% formamide in 2× SSC (twice for 15 min each), 2×
SSC (10 min), and 0.25× SSC (twice for 5 min each).
Hybridized probes were labeled with FITC-avidin
(Vector Laboratories; 1:500 in 4× SSC plus 0.5% BSA),
and signals were amplified by using biotinylated anti-
avidin (Vector Laboratories; 1:250), followed by another
round of FITC-avidin staining. Finally, cells were equili-
brated in PBS, stained for DNA with Hoechst 33,258
(0.5 μg/ml), and mounted in Fluoromount G (Fisher
Scientific, Newark, Del.).
Probe preparation-Nick translation
The plasmid pZIKVMR766 containing the whole ZIKV
cDNA was used to be labeled with biotin-11-dUTP by
nick translation. The DNase concentration for nick
translation was adjusted to yield probe DNA 200 to
500 bp in length. Probe DNA was dissolved at 10 ng/μl
in Hybrisol VII (Oncor, Gaithersburg, Md.) containing
100 ng of salmon sperm DNA (Gibco-BRL), 1 μg of
yeast tRNA (Sigma), and 0.5 mg of cot1 DNA
(Gibco-BRL)/μl.
Confocal microscopy
Cells were examined with a Leica TCS SPII confocal laser
scanning system. Two or three channels were recorded
simultaneously and/or sequentially and controlled for pos-
sible breakthrough between the fluorescein isothiocyanate
and Texas Red signals and between the blue and red
channels.
Results
ZIKV MR766 and PRVABC59 have a similar permissiveness
spectrum in human cell lines
Phylogenetic studies based on viral nucleotide and
amino acid sequences classify Zika viruses into African
and Asian lineages [3, 4, 15]. ZIKV MR766 was isolated
from Uganda in 1947 and is the representative of
African strains [14]. PRVABC59 strain was isolated in
2015 from a Puerto Rican patient who was infected by a
Brazilian strain [4]. According to the phylogenetic
studies, PRVABC59 stands for an Asian strain [4]. We
were curious about whether they have a different per-
missiveness spectrum in cell lines of human, monkey
and mouse.
Several methods were employed to determine the
permissiveness of ZIKV in different types of cell lines as
listed in Table 1. First, we performed immunofluorescence
assay (IFA) combined with RNA in situ hybridization
(RISH). We infected cells with MR766 or PRVABC59 (PR)
for 24 h at an MOI of 0.5. After fixation with 1% parafor-
maldehyde, the cells were permeabilized and immuno-
stained for viral E protein with anti-E protein antibody in
red. After refixation with 4% paraformaldehyde, the cells
were hybridized with biotin-labeled DNA probe made by
Nick translation [16] from a plasmid carrying the whole
DNA derived from ZIKV genomic cDNA that was synthe-
sized by the Genescript Inc. (Piscataway, NJ). The RNA
was stained in green with FITC-avidin. The cell nuclei
were shown in blue using DAPI staining. If the infection
rate was greater than 70%, it is set as “++++” in both IFA
(red) and RISH (green). The method for defining the in-
fection rate was referenced to that used for cytomegalo-
virus infection [17] and described in the legend of Table 1.
First, as shown in Additional file 1: Figure S1, we in-
fected Vero cells with MR766 strain or PRVABC59
strain at the same MOI (0.5) for 24 h. The cells were
fixed for immunostaining with anti-E protein in red and
RISH for RNA in green. After repeating the experiments
independently for 3 times, as can be seen in the
Additional file 1: Figure S1, there is no differences
regarding the infection rate, RNA replication pattern
and E protein production between the two strains.
Consistent with other reports [10, 11], the A549 cell
(an epithelial cell line from lung cancer) was confirmed
to be permissive for ZIKV infection (Fig .1a). We found
that other epithelial cells including ARPE-19 (Fig. 1b)
and HEK 293 T (Fig. 1c) are also permissive for ZIKV
infection. In contrast, HEp-2 and HT1080 cells are not
(or poorly) permissive for ZIKV infection. We tested the
ZIKV infection in an endothelial cells (SLK). The endo-
thelial cells did not support the ZIKV replication.
Inconsistent with another report [11], we found that
ZIKV had different replication patterns in lines of hu-
man fibroblast cells. To examine the permissiveness of
ZIKV in human fibroblast cells, we infected a human
foreskin fibroblast (BJ, ATCC) and an HFF used in our
laboratory previously for cytomegalovirus infection, and
MRC-5 (human lung fibroblast). MRC-5 (Fig. 1d) are
permissive for ZIKV infection, particularly the MRC-5
showed a better infection rate for ZIKV than Vero cells.
However, the HFF in our laboratory and the BJ cell line
from ATCC were not permissive for viral infection,
which is different from the report from Hamel et al. that
HFF was found to be completely permissive [11]. The
permissiveness of ZIKV in human lung fibroblast cells
(MRC-5) and in lung epithelial cell (A549) creates a new
hypothesis that the ZIKV may infect and replicate in the
human lung.
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Mosquitos transmit ZIKV by direct contacting blood
of the ZIKV carriers. We wondered whether ZIKV could
grow in blood cells. We selected three kinds of blood
source cells or blood cells (CEM/CD4 T cell, THP-1
monocyte, and PBMC). We found that PBMC is permis-
sive for ZIKV infection (Fig. 1e), however the ZIKV
cannot replicate in the T cell line and monocytes by the
methods tested in our experiments. We, at this point, do
not know which type of the blood cells are permissive
for ZIKV infection. The observation that ZIKV infects
PBMC is important because it suggests a mechanism for
how ZIKV viremia is maintained. The maintenance of
Fig. 1 ZIKV RNA replication in different cell lines by RISH. ZIKV MR766 was used to infect different cell lines as indicated for 24 h at an MOI of 0.5.
IFA was performed to show viral protein (red) and RISH was performed to show viral RNA replication (green). DAPI was used to show nuclei in
blue. Scale bar: 10 μm. a A549, b ARPE-19, c HEK 293T, d MRC-5, e PBMC, f U-251MG, g SK-N-SH, h Cos7
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viral load in blood is important for ZIKV transmission
by mosquitos [18].
The major medical problem caused by ZIKV infection
is that it interferes with fetal development by causing
microcephaly [19, 20]. ZIKV is infectious to the neural
stem cells [10]. Here, we found that SK-N-SH, a neuro-
blastoma cell line that displays epithelial morphology, is
also highly permissive for ZIKV infection (Fig. 1g). The
effects of ZIKV infection on the stem cell proliferation
has been studied for neural stem cells [10, 12, 21, 22],
but it has not been reported from other type of cells in
brain. We tested the permissiveness of ZIKV on a
glioblastoma cell line (U-251MG) which is from a brain
tumor. We found that U-251MG is highly permissive for
ZIKV infection (Fig. 1f ). The viral E protein and RNA
production were shown to be comparable to these in
Vero cells.
In addition, we verified that Cos7 cell line is permissive
for ZIKV infection (Fig. 1h). Two cell lines from mouse
(NIH3T3 and MEF-mouse embryo fibroblast) did not
support ZIKV infection.
All the positively permissive cell lines are shown in Fig. 1,
and the cell permissiveness is summarized in Table 1.
RNA replication or viral protein production was further
demonstrated in permissive cells by real-time RT-PCRs or
western blots
The RNA replication compartments shown by the RISH
assay certainly shows viral RNA replication. To quantita-
tively determine the ZIKV RNA replication in real-time,
we performed a real-time RT-PCR to examine the viral
RNA level at different time points post infection in all
kinds of the cells with an MOI of 0.1. The cell names
are listed in the Table 1. We selected the results in a
curve graph for all the permissive cells and the cells pre-
viously reported including HFF, Vero and A549. As can
be seen in the Fig. 2, our real-time RT-PCR results are
consistent with that of IFA and RISH studies (Table 1
and Fig. 1). A ZIKV RNA multiplication curve repre-
sents a RNA replication pattern and is defined as posi-
tive replication. ZIKV RNA level did not increase at all
in HFF and BJ cells after infection overtime. In most
permissive cells, viral RNA began to increase at time of
24 h after infection, but it started rising in U-251MG,
A549 and SK-NSH cells at 12 hpi. In summary, we
revealed that at least 7 different human cell lines (U-
251MG, MRC-5, A549, ARPE-19, PBMC, SK-N-SH, and
HEK293T) are permissive for ZIKV infection.
In addition, we performed a western blot assay to
examine the viral protein productions following the
infection of ZIKV in each cell line at MOI of 0.5. The
samples were collected at the indicated time after infec-
tion (mock, 12 hpi, 24 hpi, and 48 hpi as shown in Fig. 3).
After separated in a gradient PAGE gel (ThermoFisher
Scientific.), the protein was tranfered to a membrane for
blotting with anti-NS3 antibody. As can be seen, our
results of western blot assay are consistent to those of
real-time RT-PCR. ZIKV is more infectious to Vero, SK-
N-SH, U-251MG, MRC-5 and A549 than to PBMC,
293 T, HT1080 and ARPE-19. Its infection in HFF or
HT1080 only produced very weak protein at 48 hpi that is
not detectable in another human foreskin fibroblast cell
line, BJ. Therefore, we identified 7 more human cell lines
that are permissive for ZIKV infection.
Viral protein is detected ahead of viral replicative RNA by
IFA and RISH
Generally, at the early time of viral infection, some viral
proteins need to interact with cellular proteins to form a
restricted compartment that is utilized by the the virus
for viral DNA/RNA replication. For most RNA viruses,
RNA replication occurs in the cytoplasm [23]. If proteins
of ZIKV are important for viral RNA replication and
forms a pre-replication compartment, the viral proteins
should be produced before RNA replication occurs. To
demonstrate the presumption, we performed an IFA to
examine viral E protein production and a RISH to exam-
ine viral RNA replication with a time course of infection
in Vero cells.
As shown in Fig. 4, we infected Vero cells with ZIKV
MR766 at an MOI of 0.5. The cells were fixed at 6, 12
and 24 hpi. To show the overlapping of viral E protein,
RNA, and nuclei, the images were merged. In the
merged panels, RNA was shown in green, viral E protein
was in red, and DAPI was used to show nuclei in blue.
At 6 hpi, neither viral E protein nor viral RNA was de-
tected. At 12 hpi, viral E protein was clearly produced in
many cells but viral RNA was not able to be seen. At
24 hpi, more cells were positive with the E protein stain-
ing than that at 12 hpi. Both viral E protein and RNA
were detected at this time point, and viral RNA replication
occured in the E protein-formed domains. Therefore, we
revealed that viral E protein is produced before viral RNA
replication. The results also imply that the viral E protein
may be important for viral RNA replication.
Viral E protein directly interacts with viral RNA
As we saw that the E protein always overlapped with
viral replicative RNA in our IFA and RISH experiment,
we wondered whether the E protein interacts with viral
RNA. An interaction between the protein and viral RNA
always suggests the importance of the viral protein in
viral RNA replication. To confirm the interaction of viral
RNA with viral protein, we employed an RNA ChIP
assay. For so doing, we designed 2 sets of primers that
continuously cover the 1051 nt at the 5′ side of the
genome and 745 nt at its 3′ side, respectively (shown in
Fig. 5a). To design the primers, we considered to have
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15–20 nt overlapping between the neighboring PCR
fragments and the resultant PCR fragments are 150–
180 bp. The sequences and positions of the primers are
summarized and listed in Table 2.
After infected with ZIKV MR766 for 24 h at an MOI
of 0.5, the Vero cells were fixed and sonicated to shear
the viral genome to a range of 250–500 nt. The RNA-
protein complexes were then pulled down by anti-ZIKV
antibody-conjugated beads. After careful washing, the
beads were then eluted, and the eluate (containing RNA,
DNA, and proteins) was treated with proteinase K and
DNase I (RNase free). The RNA was finally precipitated
and used for RT-PCR. We performed the end point RT-
PCR (Fig. 5b) and real-time RT-PCR (Fig. 5c). As can be
Fig. 2 ZIKV RNA replication in different cell line by real-time RT-PCR. The cells as indicated were infected with ZIKV MR766 at an MOI of 0.1. The
cells were collected at the time points as indicated the X axis for RNA isolation. The RNA samples were then applied for real-time RT-PCR using
the primers as shown in the section of “Methods”
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seen in Fig. 5b, the PCR products showed a strong band
in the 2nd, 6th and 11th lanes. The 2nd (nt 135–294)
and 6th (nt 734–899) lanes respond the nucleotides
within the first 1051 nt of viral genome, while the 11th
(nt 10,474–10,644) lane reflects the nucleotides in the 3′
UTR of viral genome. The real-time RT-PCR shown in
Fig. 5c is consistent with the results of the regular RT-
PCR: the 3 peaks are correspondent to the 3 stronger
bands seen in the Fig. 5b. Therefore, our RNA ChIP
assay results demonstrated that the viral E protein inter-
acts with viral replicative RNA. At least three E protein-
binding sites were identified in the ZIKV MR766 RNA
genome.
ZIKV RNA co-localizes with ER, and is probably associated
with Golgi apparatus and mitochondria
The ER, mitochondria, and Golgi apparatus are cytoplas-
mic organelles with special biological functions. Since
flaviviruses, containing positive single strand RNA gen-
ome, replicate in the cytoplasm, we wondered whether
ZIKV RNA replication could associate with any of the
cytoplasmic organelles. For doing so, we infected Vero
cells with MR766 at an MOI of 0.5 for 48 h. The
cells were then fixed for immunostaining in red using
anti-Giantin antibody for visualizing Golgi apparatus,
anti-Cox IV antibody for showing mitochondria, and
anti-Calreticulin for examining ER. Then the cells
Fig. 3 Western blot assay to examine the ZIKV protein production. ZIKV MR766 was used to infect the cell lines as indicated at an MOI of 0.5. The
whole cell lysate (WCL) samples were collected at the time (hours post infection-hpi) as indicated on the top. Western blot assay was performed
to examine the viral protein production using an anti-NS3 antibody. Tubulin was used as an internal sample loading control
Fig. 4 Viral protein was produced ahead of viral RNA replication. Vero cells were infected with ZIKV MR766 at an MOI of 0.5. The cells were fixed
at 6, 12 and 24 hpi. IFA and RISH were performed to show the production of viral protein and RNA. In the merged panels, RNA was shown in
green, viral protein was in red, and DAPI was used to show nuclei in blue. Scale bar: 10 μm
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were hybridized with ZIKV-specific probe to show viral
replicative RNA in green. As can be seen in Fig. 6, the
replicated ZIKV RNA colocalizes with ER (C1-C3).
Although the replicated RNA is not overlapping with the
mitochondria and Golgi apparatus, the mitochondrial and
Golgi proteins are surrounding the RNA replication do-
mains as shown by the arrows (A1-A3 and B1-B3). There-
fore, the cytoplasmic apparatus may play important roles
in ZIKV RNA replication.
Discussion
During the evolution of the ZIKV, it appears that the
ZIKV underwent a pathogenic differentiation: Asian
lineage ZIKV has been linked to recent epidemics and
high likely the congenital microcephaly and GBS while
African strains cause milder symptoms. However, how
the ZIKV infection results in the neural diseases is not
fully understood. The knowledge of the molecular bio-
logical interactions of the ZIKV with host are lacking,
Fig. 5 RNA chromatin immunoprecipitation (ChIP) assay to determine the interaction of ZIKV protein with viral RNA. a The diagram of ZIKV genome
and the area covered by the primers listed in Table 2: 5′ side, from 1 to 1051; 3′ side, from 10,031 to 10,776. b RNA ChIP assay examined by regular
RT-PCR. The Vero cells were infected with ZIKV MR766 at an MOI of 0.5 for 24 h. Then the cells were fixed with 4% formaldehyde. The cells were then
sonicated to shear the RNA to 250–500 nt. The samples were then divided into 3 part: 1) input, 2) normal mouse IgG-precipitation, and 3) anti-ZIKV
antibody precipitation. In both 2) and 3), the RNA-protein complex was pulled down using an anti-ZIKV mouse serum generated from a ZIKV-infected
mouse or the normal mouse IgG (as negative control) with the beads. After washing for 3 cycles, the protein was digested with proteinase K, and
the DNA was removed by DNase I (RNase free). The input RNA and the ChIPed RNA samples were then precipitated and the samples were used for
RT-PCR. The PCR products were applied to run an agarose gel and visualized. c RNA ChIP assay examined by real-time RT-PCR. The same as B, but used
a real-time RT-PCR. The yields of PCR from ChIPed RNA or from input RNA were normalized to IgG. The ratio of PCR products from ChIPed RNA were
then compared to the input shown as % Input
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although it is critical to develop anti-ZIKV strategies.
Although it is believed that ZIKV infection can be
transmitted via Aedes species mosquito biting and/or
sexually, other transmission route may exist [24]. Viral
transmission is related to cell permissiveness for infec-
tion. Here, we performed comparative studies of cell
permissiveness for ZIKV African strain (MR766) and
Asian strain (PRVABC59). Both strains infect a wide
range of human cell types. No significant difference was
found in terms of RNA replication and viral protein pro-
duction in those cells between the two strains. Further
studies are needed to figure out whether they have
differences in viral RNA replication and infection at in
vivo level.
Viral permissiveness may relate viral replication to
viral transmission and spreading. For example, one of
the spreading routes of ZIKV is by Aedes mosquito bit-
ing [6, 7]. The most substance the mosquito obtains
from the ZIKV-carrying host is blood, which is also the
source of mosquito infection. We tested endothelial cell
for the infection of ZIKV and found that the endothelial
cells are not permissive for ZIKV infection. Importantly,
our IFA, RISH, and real-time RT-PCR experiments dem-
onstrated that ZIKV productively infects the PBMC
(Figs. 1 and 2, Table 1). Although we do not know yet
which type of blood cells are permissive for ZIKV infec-
tion, our finding that ZIKV infects PBMC suggests that
PBMC is the source of blood virus and is important for
maintenance of viral level in the blood.
It has been reported that a great number of viral parti-
cles of ZIKV were detected in brain tissue and fluid [25].
It has been reported that ZIKV productively infects
neural stem cell [10, 12, 21, 22]. Another important cell
line that supports ZIKV infection is U-251MG (Figs. 1
and 2, Table 1). U-251MG is a glioblastoma cell line and
derived from brain. Our results showed that ZIKV
replicates in U-251MG productively, which may suggest
another factor that enhances the ZIKV pathogenesis in
brain. Further studies using a mouse model will be
necessary to confirm our hypothesis that ZIKV infects
different types of cells in brain tissue to affect the devel-
opment of the fetal brain.
ZIKV is a member of the family Flaviviridae. It
contains a positive and single stranded RNA genome.
Viral protein can be produced immediately after viral
entry, which is consistent with our finding that viral
protein was detected before viral RNA replication can be
seen (Fig. 4). Flaviviral genome replication requires three
steps: 1) negative strand RNA synthesis, 2) positive
strand RNA synthesis, and 3) 5′-RNA capping and
methylation. Before viral RNA replication, a pre-
replication complex needs to be formed [26, 27]. The
pre-replication complex contains both viral and cellular
proteins. Some of these proteins may be able to bind to
viral RNA. Our RISH and IFA results showed that the
viral replicative RNA localizes in the cytoplasm as a do-
main that overlaps with viral E protein, forming the viral
RNA replication domain (Fig. 1). In this study, RNA
ChIP assays demonstrated that viral proteins directly
interact with viral RNA (Fig. 5). At least 3 binding sites
have been identified in the viral genome for the viral E
protein binding (Fig. 5). This results is surprising be-
cause E protein is a structural protein of ZIKV and func-
tions as an initiator of viral infection through interacting
Fig. 6 Association of ZIKV RNA replication with cellular organelles. Vero cells were infected with MR766 at an MOI of 0.5 for 24 h. The cells were
then fixed for immunostaining in red using anti-Cox IV antibody for showing mitochondria (A1-A3), anti-Giantin antibody for visualizing Golgi
apparatus (B1-B3), and anti-Calreticulin for examining ER (C1-C3). Then the cells were hybridized with ZIKV-specific probe to show viral replicative
RNA in green. DAPI was used to show nuclei in blue. Scale bar: 10 μm
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with cell receptor. However, we found that E protein
presents continuously in the viral replication compart-
ments. The finding that E protein interacted with viral
RNA implies that E protein may play roles in viral
replication. This is important because the protein-RNA
interaction may be an effective target for designing the
intervention drugs against viral RNA replication.
Lastly, we revealed that the viral replication occurs in
ER (Fig. 6C1–C3), which is consistent with the report
for other flaviviral RNA replication [26, 27]. Although
the RNA replication compartment is not colocalizing
with mitochondria or Golgi apparatus, the matrix
protein of mitochondria is shown surrounding the RNA
domain as shown by the arrow in the Fig. 6A1-A3. A
similar observation was also shown for Golgi apparatus
in the Fig. 6B1-B3. This information suggests that the
cellular organelles may play different roles in ZIKV viral
replication.
In summary, we employed different techniques to de-
termine the ZIKV infection permissiveness in human
cells, the two strains have a similar permissiveness in hu-
man cells. More experiments are needed to reveal the
differences between Asian and African strains because it
is important to know why only the strains derived from
Asian linage cause microcephaly. We revealed that ZIKV
can replicate to a high titer in human lung fibroblast
cells, which imply that ZIKV can replicate in the lung.
PBMC is permissive for ZIKV replication, which is
important because the information may explain why the
mosquito is the transmitter for ZIKV. We also discov-
ered that viral protein directly interacts with viral gen-
ome via binding to different sites of the viral genome.
We will test whether the protein-RNA interaction can
be a target for designing drugs to intervene the viral
replication and infection.
Conclusions
Our results that E protein of ZIKV interacts with viral
RNA imply that the E protein may be important for viral
RNA replication. Our results provide not only the infor-
mation of ZIKV permissiveness that guides the usage of
human cells for the ZIKV studies, but also the insight
into the viral RNA-E protein interaction that may be
targeted for intervention by designing small molecule
drugs. Our future studies will be focused on how the
ZIKV infection permissiveness is determined by virus-
host interactions.
Additional file
Additional file 1: Figure S1. Immunofluorescent assay and RISH to
show ZIKV viral RNA replication and protein production in Vero cells. Vero
cells were infected with MR766 (A1-D1, A3-D3) or PRVABC59 (PR) (A2-D2,
A4-D4) at an MOI of 0.5 for 24 h. After fixation with 1% formaldehyde,
the cells were permeabilized and immunostained for viral protein in red
(B1-B4). After refixation with 4% formaldehyde, the cells were hybridized
with single strand DNA probe (labeled with biotin) made from ZIKV
genomic DNA. The RNA was stained in green (A1-A4). The cell nuclei
were shown in blue using DAPI staining (C1-C4). The merged image was
shown in D1-D4. In the panels 1 and 2, the pictures were taken using a
40× lens. In the panels 3 and 4, the pictures were taken using an 100×
lens. Scale bar: 10 μm. (PSD 5413 kb)
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